Project Grant R21MH128815
- This is a $223,176 Project Grant awarded by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), to Beth Israel Deaconess Medical Center, Inc. in Boston, MA. The grant funds a research project that aims to use high-definition transcranial direct current stimulation (HD-tDCS) to the right superior temporal sulcus (rSTS) as a potential treatment approach for reducing auditory and visual hallucinations associated with psychosis-spectrum...
- This federal Project Grant award of $777,016.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a study on the synaptic mechanisms underlying repetitive transcranial magnetic stimulation (rTMS) protocols for the treatment of treatment-resistant depression. The study, titled "Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression," aims to investigate the neural mechanisms of the inhibitory...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $236,098 to The Trustees of the University of Pennsylvania to elucidate the glutamatergic mechanisms of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder. The research aims to use cutting-edge ultra-high field (7T) neuroimaging techniques, including glutamate chemical exchange saturation transfer...
- This Project Grant award, provided by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports research to establish reliable markers of prefrontal excitability that can be used to optimize repetitive transcranial magnetic stimulation (rTMS) treatment for depression. The $784,096 award, with a project period from May 1, 2025 to February 28, 2030, will allow researchers at The Leland Stanford Junior University to: 1) investigate how...
- The National Institute of Mental Health (NIMH) awarded a $830,409 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, to develop novel software and computational techniques that integrate real-time navigated electric-field mapping and source-space electroencephalogram (EEG) analysis during transcranial magnetic stimulation (TMS) to improve the accuracy of targeting and dosimetry for...
- This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants provides $638,872 to The Feinstein Institutes for Medical Research to conduct research on "Elucidating Reward Network Modulation in Medial Forebrain Bundle Deep Brain Stimulation for Treatment Resistant Depression". The goal is to use brain imaging to understand how deep brain stimulation of the medial forebrain bundle impacts the brain's reward processing...
- This Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports a research project titled "VISUAL PERCEPTION IN SCHIZOPHRENIA: ASSESSING PREDICTIVE PROCESSING IN THE EARLIEST STAGES OF THE VISUAL CORTICAL HIERARCHY". The $423,500 award to the University of Rochester aims to use innovative visual stimuli and high-density electroencephalography (EEG) to investigate the relationship between...
- The National Science Foundation (NSF) Directorate for Engineering awarded the University of Pittsburgh a 3-year, $350,000 Project Grant to develop an innovative closed-loop brain-computer interface (BCI) system for use in exposure therapy for socially fearful teenagers with depression and anxiety. The proposed technology synchronizes electroencephalogram (EEG) monitoring with augmented reality (AR) simulations of social fear scenarios, enabling real-time detection of fearful responses and...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $184,476 to the University of Southern California to conduct a large-scale mapping of brain morphometry in Bipolar Disorder (BD) and Major Depressive Disorder (MDD). The project builds on 15 years of research by the ENIGMA Consortium's BD working group, applying standardized voxel-wise brain mapping techniques to a sample of 3,500 BD patients,...
- This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA 93.242 Mental Health Research Grants program, will provide $1,651,499.00 over 3 years to Magnetic Tides, Inc. to assess the proof-of-mechanism and efficacy of their novel Kilohertz Transcranial Magnetic Perturbation (KTMP) device for treating anhedonia in patients with major depressive disorder. The goal is to use KTMP to precisely modulate brain activity in the reward circuitry, specifically targeting the...
EXOGENOUS MODULATION OF VISUAL PERCEPTION AND CONNECTIVITY IN BODY DYSMORPHIC DISORDER (EMPAC-BDD) - PROJECT SUMMARY INDIVIDUALS WITH BODY DYSMORPHIC DISORDER (BDD) MISPERCEIVE ASPECTS OF THEIR APPEARANCE TO BE CONSPICUOUSLY FLAWED OR DEFECTIVE, DESPITE THESE BEING UNNOTICEABLE OR APPEARING MINISCULE TO OTHERS. WITH CONVICTIONS OF DISFIGUREMENT AND UGLINESS, THEY TYPICALLY HAVE POOR INSIGHT OR DELUSIONAL BELIEFS, OBSESSIVE THOUGHTS AND COMPULSIVE BEHAVIORS, ANXIETY, AND DEPRESSION. THESE RESULT IN SIGNIFICANT DIFFICULTIES IN FUNCTIONING, DEPRESSION, SUICIDE ATTEMPTS (25%), AND PSYCHIATRIC HOSPITALIZATION (50%). DESPITE THIS, RELATIVELY FEW STUDIES OF THE NEUROBIOLOGY, AND FEW TREATMENT STUDIES, HAVE BEEN CONDUCTED. THIS UNDERSCORES A CRITICAL NEED FOR RESEARCH TO IDENTIFY NOVEL TARGETS FOR INTERVENTION BASED ON A COMPREHENSIVE UNDERSTANDING OF THE PATHOPHYSIOLOGICAL MECHANISMS. PREVIOUS RESEARCH HAS UNCOVERED MECHANISMS THAT MAY CONTRIBUTE TO PERCEPTUAL DISTORTIONS, INCLUDING PROMINENT ABNORMALITIES IN VISUAL PROCESSING SYSTEMS. THESE HAVE CONTRIBUTED TO A MODEL OF DIMINISHED GLOBAL/HOLISTIC PROCESSING AND ENHANCED LOCAL/DETAILED PROCESSING, ATTRIBUTED TO "BOTTOM-UP" AND "TOP-DOWN" DISTURBANCES IN PERCEPTION. PREVIOUS EXPERIMENTS USING PSYCHOPHYSICAL TESTS, NOVEL BEHAVIORAL VISUAL MODULATION TECHNIQUES, AND FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) HAVE PROBED THE BRAIN'S VISUAL SYSTEMS RESPONSIBLE FOR GLOBAL AND LOCAL PROCESSING AND FOUND EARLY EVIDENCE THAT THEY MAY BE MODIFIABLE IN BDD. THIS STUDY WILL TEST IF FURTHER MODIFICATION COULD BE ACHIEVED USING NONINVASIVE NEUROMODULATION WITH REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (TMS). SUCH MODULATION MAY BE NECESSARY TO ENHANCE THE EFFECTS OF BEHAVIORAL MODULATION AND INDUCE THE MAGNITUDE OF FUNCTIONAL CHANGES NECESSARY TO ACHIEVE CLINICALLY MEANINGFUL IMPROVEMENTS IN PERCEPTUAL EXPERIENCES IN THOSE WITH BDD. THE PROPOSED EXPERIMENT WILL DETERMINE WHETHER EXCITATORY AND INHIBITORY TMS ENHANCES AND INHIBITS, RESPECTIVELY, THE EFFECTS OF A BEHAVIORAL VISUAL MODULATION STRATEGY ON BRAIN CONNECTIVITY AND ON GLOBAL VISUAL PROCESSING ON A PSYCHOPHYSICAL TASK. THIS WILL BE TESTED IN INDIVIDUALS WITH CLINICAL BDD AND IN INDIVIDUALS WITH SUBCLINICAL BDD. RESULTS WILL CONTRIBUTE TO A COMPREHENSIVE MECHANISTIC MODEL OF ABNORMAL VISUAL INFORMATION PROCESSING UNDERLYING THE CORE SYMPTOM DOMAIN OF MISPERCEPTIONS OF APPEARANCE. FURTHER, RESULTS WILL BE CRITICAL FOR THE DEVELOPMENT AND OPTIMIZATION OF FUTURE COMBINATIONS OF NEUROMODULATION AND NOVEL PERCEPTUAL RETRAINING TREATMENTS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 7/28/25 | ||
| Not listed | $0 | 7/24/23 | ||
| Not listed | $136.4k | 7/21/23 | ||
| Not listed | $136.4k | 6/29/22 | ||
| Not listed | $136.4k | 6/29/22 |